Description: This session is about recent population experience, likely causes, probable future prospects, Industry mortality differentials and trends by product line,market and type of underwriting, What statistically credible evidence do we have for the efficacy of life insurance underwriting practices, What does the new Intercompany Standard Issues study show and Are there sound biological laws of mortality. From Record of Society of Actuaries Vol. 5, No. 4.